Epidemiology of renal cell carcinoma: 2022 update Review


Authors: Bukavina, L.; Bensalah, K.; Bray, F.; Carlo, M.; Challacombe, B.; Karam, J. A.; Kassouf, W.; Mitchell, T.; Montironi, R.; O'Brien, T.; Panebianco, V.; Scelo, G.; Shuch, B.; van Poppel, H.; Blosser, C. D.; Psutka, S. P.
Review Title: Epidemiology of renal cell carcinoma: 2022 update
Abstract: Context: International variations in the rates of kidney cancer (KC) are considerable. An understanding of the risk factors for KC development is necessary to generate opportunities to reduce its incidence through prevention and surveillance. Objective: To retrieve and summarize global incidence and mortality rates of KC and risk factors associated with its development, and to describe known familial syndromes and genetic alterations that represent biologic risk factors. Evidence acquisition: A systematic review was conducted via Medline (PubMed) and Scopus to include meta-analyses, reviews, and original studies regarding renal cell carcinoma, epidemiology, and risk factors. Evidence synthesis: Our narrative review provides a detailed analysis of KC incidence and mortality, with significant variations across time, geography, and sex. In particular, while KC incidence has continued to increase, mortality models have leveled off. Among the many risk factors, hypertension, obesity, and smoking are the most well established. The emergence of new genetic data coupled with observational data allows for integrated management and surveillance strategies for KC care. Conclusions: KC incidence and mortality rates vary significantly by geography, sex, and age. Associations of the development of KC with modifiable and fixed risk factors such as obesity, hypertension, smoking, and chronic kidney disease (CKD)/end-stage kidney disease (ESKD) are well described. Recent advances in the genetic characterization of these cancers have led to a better understanding of the germline and somatic mutations that predispose patients to KC development, with potential for identification of therapeutic targets that may improve outcomes for these at-risk patients. Patient summary: We reviewed evidence on the occurrence of kidney cancer (KC) around the world. Currently, the main avoidable causes are smoking, obesity, and high blood pressure. Although other risk factors also contribute, prevention and treatment of these three factors provide the best opportunities to reduce the risk of developing KC at present. © 2022
Keywords: unclassified drug; gene translocation; somatic mutation; genetics; review; hypertension; cancer incidence; cancer susceptibility; risk factors; exercise; obesity; smoking; information retrieval; risk factor; renal cell carcinoma; kidney neoplasms; cancer mortality; age; risk assessment; oncogene; kidney tumor; carcinoma, renal cell; systematic review; medline; insulin resistance; sex difference; cancer epidemiology; birt hogg dube syndrome; genetic risk; kidney cancer; von hippel lindau disease; epidemiology; alcohol consumption; genetic screening; ethnicity; environmental exposure; chronic kidney failure; biological product; biological products; geography; lifestyle; succinate dehydrogenase; complication; germline mutation; mortality rate; end stage renal disease; bap1 protein; pbrm1 protein; humans; human; scopus; succinate dehydrogenase-deficient renal cell carcinoma; hereditary papillary renal cell carcinoma; hereditary leiomyomatosis and renal cell cancer; tumors of the kidney
Journal Title: European Urology
Volume: 82
Issue: 5
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2022-11-01
Start Page: 529
End Page: 542
Language: English
DOI: 10.1016/j.eururo.2022.08.019
PUBMED: 36100483
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 November 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Isabel Carlo
    162 Carlo